← Leaderboards
Yong Li
Baylor College Of Medicine
$17,236,630
Attributed
$17,236,630
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,268,965 · 15
By mechanism
R01$15,316,461 · 9
U54$5,063,356 · 3
P30$1,292,306 · 1
R21$408,120 · 1
P20$188,722 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Bhagavatula Moorthy$21,666,412
- Chung-Che Chang$1,174,011
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMolecularCellsOncogenicMutationGenesCessation Of LifeMessenger RnaBaseSignal TransductionProteinsMutantPathogenesisResponseMediatingS LymphomaTumorigenesisBiologicalSpecimenTp53 GenePreventOverexpressionNucleotidesIncidence
Grant awards (54)
Cancer Prevention-Interception Against MGUS Progression$1,308,925
U54 · FY2025 · CA · contact PI
PD-L1 MODIFICATIONS IN CANCER DIAGNOSIS AND TREATMENT$678,723
R01 · FY2025 · CA · contact PI
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI$656,085
R01 · FY2025 · CA · contact PI
Optimizing Syngeneic Mouse Models to Target Mutant p53$596,803
R01 · FY2025 · CA · contact PI
Administrative Core$327,232
U54 · FY2025 · CA · contact PI
Prevent IgM MGUS Progression by Targeting the Driver Mutation$327,231
U54 · FY2025 · CA · contact PI
Cancer Prevention-Interception Against MGUS Progression$1,078,336
U54 · FY2024 · CA · contact PI
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI$623,283
R01 · FY2024 · CA · contact PI
Optimizing Syngeneic Mouse Models to Target Mutant p53$566,963
R01 · FY2024 · CA · contact PI
Administrative Core$226,683
U54 · FY2024 · CA · contact PI
DELINEATE THE TUMOR IMMUNE MICROENVIRONMENT FOR BETTER UNDERSTANDING IMMUNOTHERAPY RESPONSE$186,712
U54 · FY2024 · CA · contact PI
Administrative Core$186,712
U54 · FY2024 · CA · contact PI
Cancer Prevention-Interception Against MGUS Progression$1,166,056
U54 · FY2023 · CA · contact PI
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI$656,085
R01 · FY2023 · CA · contact PI
Optimizing Syngeneic Mouse Models to Target Mutant p53$596,803
R01 · FY2023 · CA · contact PI
Administrative Core$255,469
U54 · FY2023 · CA · contact PI
Dietary Carcinogens for Colorectal Cancer$358,680
R01 · FY2022 · CA · contact PI
TP53 Germline Mutations: Beyond LFS$358,677
R01 · FY2022 · CA · contact PI
Dietary Carcinogens for Colorectal Cancer$366,000
R01 · FY2021 · CA · contact PI
TP53 Germline Mutations: Beyond LFS$366,000
R01 · FY2021 · CA · contact PI
Dietary Carcinogens for Colorectal Cancer$366,000
R01 · FY2020 · CA · contact PI
TP53 Germline Mutations: Beyond LFS$366,000
R01 · FY2020 · CA · contact PI
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma$384,959
R01 · FY2019 · CA · contact PI
TP53 Germline Mutations: Beyond LFS$330,503
R01 · FY2019 · CA · contact PI
Modulation of MicroRNAs with Xenobiotics to Target c-Myc$278,699
R01 · FY2019 · CA · contact PI
Dietary Carcinogens for Colorectal Cancer$253,278
R01 · FY2019 · CA · contact PI
Dietary Carcinogens for Colorectal Cancer$101,741
R01 · FY2019 · CA · contact PI
Modulation of MicroRNAs with Xenobiotics to Target c-Myc$72,992
R01 · FY2019 · CA · contact PI
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma$70,274
R01 · FY2019 · CA · contact PI
TP53 Germline Mutations: Beyond LFS$27,533
R01 · FY2019 · CA · contact PI
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma$457,439
R01 · FY2018 · CA · contact PI
TP53 Germline Mutations: Beyond LFS$377,037
R01 · FY2018 · CA · contact PI
Dietary Carcinogens for Colorectal Cancer$366,000
R01 · FY2018 · CA · contact PI
Modulation of MicroRNAs with Xenobiotics to Target c-Myc$362,569
R01 · FY2018 · CA · contact PI
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma$448,485
R01 · FY2017 · CA · contact PI
Modulation of MicroRNAs with Xenobiotics to Target c-Myc$368,974
R01 · FY2017 · CA · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$334,629
R01 · FY2017 · CA · contact PI
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma$439,795
R01 · FY2016 · CA · contact PI
Modulation of MicroRNAs with Xenobiotics to Target c-Myc$368,859
R01 · FY2016 · CA · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$312,294
R01 · FY2016 · CA · contact PI
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma$445,986
R01 · FY2015 · CA · contact PI
Modulation of MicroRNAs with Xenobiotics to Target c-Myc$383,141
R01 · FY2015 · CA · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$327,043
R01 · FY2015 · CA · contact PI
MicroRNAs as Biomarkers for Tobacco Exposure and Heart Disease$183,120
R21 · FY2015 · HL · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$353,787
R01 · FY2014 · CA · contact PI
MicroRNAs as Biomarkers for Tobacco Exposure and Heart Disease$225,000
R21 · FY2014 · HL · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$326,506
R01 · FY2013 · CA · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$396,576
R01 · FY2012 · CA · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$150,411
R01 · FY2011 · CA · contact PI
Center for Environmental Genomics and Integrative Biology$1,292,306
P30 · FY2010 · ES · contact PI
Role of Retroelements in Environmental Atherogenesis$370,000
R01 · FY2010 · ES · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$331,526
R01 · FY2010 · CA · contact PI
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental Co$319,323
R01 · FY2009 · CA · contact PI
CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH: PROJECT 5$188,722
P20 · FY2009 · RR · contact PI